2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Clostridium Difficile Infection: new trials by email Literature Review of Clostridium Difficile Infection trials Research Report on Clostridium Difficile Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients FMT Capsule DE, Placebo oral capsule - Clostridium Difficile Infection | Phase 2 | Withdrawn | University of Wisconsin, Madison | 2022-09-01 | 2021-02-23 | |
| Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections MIYA-BM Fine Granules (CBM588), Placebo Fine Granules (without CBM588) - Clostridium Difficile Infection | Phase 2 | Withdrawn | Osel, Inc. | 2010-02-01 | 2013-11-11 |
Clostridium Infections (2) · Bacterial Infections (1) · Colitis (1) · Colonic Diseases (1) · Diarrhea (1) · Digestive System Diseases (1) · Enterocolitis (1) · Enterocolitis, Pseudomembranous (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Gram-Positive Bacterial Infections (1) · Intestinal Diseases (1)
Bacterial Infections and Mycoses (2) · Infections (2) · Bacterial Infections (1) · Gram-Positive Bacterial Infections (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Fecal Microbiota Transplantation (1)
Osel, Inc. (1) · University of Wisconsin, Madison (1)